Novatox 100 Clostridium botulinum ATCC 3502 100 IU – KG Medics S.Korea

• Use of strains identified with Clostridium botulinum ATCC 3502

​

• Securing  stable  production

       process   technology  by simplifying         the undiluted solution manufacturing

       process

​

•  Production  of more  than  99% of undiluted solution

  
  

  Technology
  development
  capabilities

  • Expect  safe product   production/  management   through bio  factories equipped with state-of-the-art production facilities

  ​

  • Institute – 2,704 ,000  Vials can  be produced   annually with Botox Production Plant  &  Research